Abstract
This paper describes the development and validation of an HPLC method for the determination of protein bound and total lipoic acid in human plasma. The essential steps in the total lipoic acid assay include reduction of disulfide bridge with tris(2-carboxyethyl)phosphine, derivatization via thiol group with 1-benzyl-2-chloropyridinium bromide and HPLC analysis of S-pyridinium derivative. Protein-bound lipoic acid is first separated from free lipoic acid with the use of liquid extraction, converted to its reduced counterpart then processed as total lipoic acid. The method is reproducible, precise and accurate. The inter- and intraday related standard deviation varied from 1.5% to 11.5% and from 1.8% to 19.6%, respectively, while recovery is in the range of 80.0–106.0% and 80.4–110.8%, respectively. The mean concentration of total lipoic acid in healthy donors after supplementation with 600mg and 1200mg was 0.67±0.40μmolL−1 (137.6±82.1μgL−1) and 1.57±0.34μmolL−1 (323.34±70.07μgL−1), respectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
